TEE simulator uses patient images to improve cardiology training

Training using transesophageal echocardiography (TEE) simulators typically relies on grainy drawings of patients in black and white. But a new version, developed by a team from the University of Washington led by Florence Sheehan, MD, can display 3D images of a hypothetical patient, allowing users to look for blood clots and other abnormalities.

 “Real patient images are important because if you only look at an artist’s rendering, you can’t appreciate everything else that an image reveals. For example, the ultrasound modality creates visual artifacts that aren’t meaningful and can be misleading. You have to learn how to distinguish those from an actual pathology,” Sheehan said, in a release from the UW School of Medicine.

The new simulator uses images from actual patients instead of drawings used in standard simulators. The tool improves realism in training cardiology fellows and anesthesiology residents at the UW School of Medicine.

Software used by the TEE simulator includes seven real-life cases, allowing trainees to see 3D images instead of the “cartoons,” as Sheehan said, presented by simulators dependent on drawings.

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?